1Chu SY, Sennether LT, Bunnell ST, et al. Pharmacoki_ netics of clarithromycin, a new marcrolide, affer singleascending ascending oral dose[J]. Antimicrob Agents Chemother, 1992, 36: 2 447.
2Hardy DJ, Swanson RN, Rode RA, et al. Enhancement of the in vitro and vivo activities of clarithromycin ag_ainst haemophilus influenzae by 14-hydroxy-clarifh_ romycin, ts major metabo lite in humans[J]. Antimicr_ob Agents Chemother, 1990, 34: 1 407.
3Heffelfinger JD, Dowell SF, Jorgensen JH, et al. Manag_ ement of cormmunity-acquired pneumonia in the eraof penumococcal resistance a report from the drug-resistant stretococcus pneumoniae therapeutic working group[J]. Arch, Lntern Med, 2000, 160( 10): 1 399.
4Graham DY, Opekun AR, klein PD. Clarithromycin for the eradication of Helicobacter Pylori[J]. J Clin Grastr_oentrol, 1993, 16: 292.
5Yatsunami J, Turta N, Wakamatsu K, et al. Clarithrom_ ycin is a poten inhibitor of tumor-indaceel angiogene_ sis[J]. Res Exp Med( Berl),1997, 197( 4): 189.